Baillie Gifford & CO Codexis, Inc. Call Options Transaction History
Baillie Gifford & CO
- $126 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CDXS
# of Institutions
131Shares Held
49.5MCall Options Held
33.4KPut Options Held
21K-
Black Rock Inc. New York, NY6.61MShares$19.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.46MShares$13.3 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$12.6 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA3.12MShares$9.27 Million2.65% of portfolio
-
Telemark Asset Management, LLC Boston, MA2.7MShares$8.01 Million1.1% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $195M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...